Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diamox in Normal Pressure Hydrocephalus
NCT03779594Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 2, open-label trial of acetazolamide in normal pressure hydrocephalus (NPH), sponsored by Rabin Medical Center. Primary endpoints: Change from Baseline Gait at 4 weeks and Change from Baseline Balance at 4 weeks. Status: unknown.
02
Drugs
acetazolamide
03
Conditions
normal pressure hydrocephalus (NPH)
Beyond the preview
Go deeper on NCT03779594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03779594.